# US 8,277,863 B2 · Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,277,863 B2
- Document ID: US8277863B2
- Status: Granted
- Kind: B2
- Application number: 12/497,091
- Filed: 2009-07-02
- Published: 2009-12-17
- Granted: 2012-10-02
- Earliest claimed: 2005-06-30
- Assignees: Mead Johnson Nutrition Company
- Inventors: Bryon W. Petschow; Robert J. McMahon; Glenn R. Gibson; Robert A. Rastall; Renia Gemmell; Maria Saarela; Anna-Marja Aura
- Web page: https://patentgrep.com/patent/US8277863B2

## CPC

- A61K 31/721: Dextrans
- A23L 33/26: Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- Y10S 426/801: Pediatric
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.

## Claims

### Claim 1

An infant formula comprising
a prebiotic composition comprising
a) a first prebiotic having a rate of fermentation in the intestinal tract that is slower than galacto-oligosaccharide and which comprises polydextrose and
b) a second prebiotic which comprises a prebiotic selected from the group consisting of galacto-oligosaccharide, lactulose, and combinations thereof,
wherein the prebiotic composition is present at a level of between about 2.0 g/L and about 8.0 g/L, and the ratio of the first prebiotic to the second prebiotic is between about 1:3 and about 3:1.

### Claim 2 (depends on 1)

The infant formula according to claim 1, comprising polydextrose and galacto-oligosaccharide.

### Claim 3 (depends on 1)

The infant formula according to claim 1, comprising polydextrose and lactulose.

### Claim 4 (depends on 1)

The infant formula according to claim 1, comprising polydextrose, galacto-oligosaccharide and lactulose.

### Claim 5 (depends on 1)

The infant formula according to claim 1, which further comprises
a. a lipid or fat;
b. a protein source selected from the group consisting of whey protein, casein, casein protein, nonfat milk, hydrolyzed protein and combinations thereof; and
c. about 5 to about 200 mg/100 kcal of a source of long chain polyunsaturated fatty acids.

### Claim 6 (depends on 5)

The infant formula according to claim 5, wherein the source of long chain polyunsaturated fatty acids comprises docosahexanoic acid, arachidonic acid or combinations thereof.

### Claim 7 (depends on 6)

The infant formula according to claim 6, wherein the source of long chain polyunsaturated fatty acids comprises docosahexanoic acid and arachidonic acid, further wherein the ratio of arachidonic acid to docosahexanoic acid is from about 1:3 to about 9:1.

### Claim 8 (depends on 5)

The infant formula according to claim 5, wherein the lipid or fat is present at a level of about 3 to about 7 g/100 kcal.

### Claim 9 (depends on 5)

The infant formula according to claim 5, wherein the protein source is present at a level of about 1 to about 5 g/100 kcal.

### Claim 10 (depends on 5)

The infant formula according to claim 5, which further comprises at least one probiotic.

### Claim 11 (depends on 10)

The infant formula according to claim 10, wherein the probiotic is selected from the group consisting of Bifidobacteria spp., Lactobacillus spp and combinations thereof.

### Claim 12 (depends on 1)

The infant formula according to claim 1, wherein the second prebiotic further comprises fructo-oligosaccharide, inulin, gluco-oligosaccharide, isomalto-oligosaccharide, xylo-oligosaccharide, soybean oligosaccharide, chito-oligosaccharide, gentio-oligosaccharide, manno-oligosaccharide, lactosucrose, raffinose, aribino-oligosaccharide, glucans, siallyl and fuco-oligosaccharide, or combinations thereof.

### Claim 13

An infant formula comprising a first prebiotic having a rate of fermentation slower than galacto-oligosaccharide that comprises polydextrose and a second prebiotic that comprises a combination of galacto-oligosaccharide and lactulose, wherein the amount of polydextrose present in the infant formula is about 2.0 g/L, the amount of galacto-oligosaccharide present in the infant formula is about 2.0 g/L and the amount of lactulose present in the infant formula is about 2.0 g/L.

### Claim 14

An infant formula comprising a first prebiotic having a rate of fermentation slower than galacto-oligosaccharide that comprises polydextrose and a second prebiotic that comprises a combination of galacto-oligosaccharide and lactulose, wherein the amount of polydextrose present in the infant formula is about 2.0 g/L, the amount of galacto-oligosaccharide present in the infant formula is about 1.32 g/L and the amount of lactulose present in the infant formula is about 2.6 g/L.

### Claim 15

An infant formula comprising a first prebiotic having a rate of fermentation slower than galacto-oligosaccharide that comprises polydextrose and a second prebiotic that comprises a combination of galacto-oligosaccharide and lactulose wherein the amount of polydextrose present in the infant formula is about 4.0 g/L, the amount of galacto-oligosaccharide present in the infant formula is about 2.64 g/L and the amount of lactulose present in the infant formula is about 3.6 g/L.
